- Clinically proven in myostatin reduction
- High degree of Bioavailability
- Contains 80 proteins, 700 peptides and bio-active growth factors
MYO-X by MHP represents an advance in muscle development-related science. For a long time, researchers have been trying to find a way to inhibit the production of myostatin, a natural regulator and limiter of muscle growth in humans.
MHP, courtesy of its research team, introduces MYO-X as a mechanism that manages to inhibit this factor and help athletes seeking maximum growth.
Carlon Colker, M.D., 'FACN Sports Perfomance Physician' and a group of scientists from around the world have managed to isolate a bio-active component generated through a patented process that seeks maximum bioavailability. Said product contains around 80 main proteins, hundreds of peptides, and a variety of growth factors. The patent in question is known as MyoT12®
, which works as regulator and inhibitor of myostatin activity, having been clinically validated as an agent to reduce levels of myostin in plasma with a percentage of 46% in a sample of subjects, within 12-18 hours of taking it.
It is a big step forward in the field of fitness, where 'bodybuilders' seek the most effective and resounding way to maximize muscle gain.
Regardless of how we train, we are all affected by myostin as a limiter of maximum muscle development and growth.